Sora Investors LLC Invests $3.46 Million in Aspen Aerogels, Inc. (NYSE:ASPN)

Sora Investors LLC purchased a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 125,000 shares of the construction company's stock, valued at approximately $3,461,000. Sora Investors LLC owned about 0.15% of Aspen Aerogels at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of ASPN. FMR LLC raised its holdings in shares of Aspen Aerogels by 23.6% during the 3rd quarter. FMR LLC now owns 4,050,896 shares of the construction company's stock worth $112,169,000 after acquiring an additional 773,647 shares during the period. Driehaus Capital Management LLC grew its position in Aspen Aerogels by 130.4% in the second quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company's stock worth $51,439,000 after acquiring an additional 1,220,724 shares during the period. Loomis Sayles & Co. L P increased its stake in Aspen Aerogels by 22.7% during the third quarter. Loomis Sayles & Co. L P now owns 1,619,320 shares of the construction company's stock worth $44,839,000 after acquiring an additional 300,076 shares during the last quarter. State Street Corp increased its stake in Aspen Aerogels by 0.6% during the third quarter. State Street Corp now owns 1,410,543 shares of the construction company's stock worth $39,058,000 after acquiring an additional 8,344 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in Aspen Aerogels by 21.3% in the second quarter. Dimensional Fund Advisors LP now owns 1,374,631 shares of the construction company's stock valued at $32,790,000 after purchasing an additional 240,921 shares during the period. Hedge funds and other institutional investors own 97.64% of the company's stock.

Insiders Place Their Bets

In other news, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares of the company's stock, valued at approximately $14,523,709.20. The trade was a 11.58 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 4.30% of the stock is owned by company insiders.

Aspen Aerogels Stock Down 0.7 %

Shares of NYSE ASPN traded down $0.10 during mid-day trading on Friday, hitting $13.38. The company had a trading volume of 596,716 shares, compared to its average volume of 1,628,506. The company has a market capitalization of $1.10 billion, a PE ratio of 1,350.35 and a beta of 2.11. The business's 50-day simple moving average is $18.91 and its 200 day simple moving average is $23.59. Aspen Aerogels, Inc. has a 1-year low of $10.75 and a 1-year high of $33.15. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. Roth Mkm lowered their price target on Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating for the company in a report on Friday, November 8th. Piper Sandler dropped their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating for the company in a research report on Tuesday, October 22nd. TD Cowen upped their price objective on shares of Aspen Aerogels from $36.00 to $41.00 and gave the stock a "buy" rating in a report on Tuesday, August 20th. HC Wainwright reaffirmed a "buy" rating and set a $30.00 price objective on shares of Aspen Aerogels in a research report on Wednesday, October 16th. Finally, Benchmark reissued a "buy" rating and issued a $14.00 target price on shares of Aspen Aerogels in a research report on Thursday, August 8th. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, Aspen Aerogels currently has a consensus rating of "Moderate Buy" and a consensus target price of $28.70.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.